A bi­par­ti­san group of Michi­gan law­mak­ers re­leased a new bill that could great­ly sti­fle the boom­ing cross-bor­der deals spree be­tween Chi­nese and Amer­i­can biotechs.

Rep...

Tra­vere Ther­a­peu­tics is en­list­ing the help of Chi­na-based Ever­est Med­i­cines to bol­ster its rare kid­ney dis­ease pipeline be­yond its ap­proved med­i­cine Filspari.

The San Diego...

Leg­end Biotech’s long-await­ed first show­ing of in vi­vo CAR-T da­ta is here, fu­el­ing mo­men­tum in the grow­ing field.

Leg­end re­port­ed re­sults Tues­day on 12 lym­phoma...

Back in March, Roche re­vealed that the breast can­cer pill on which it had pinned bil­lion-dol­lar sales ex­pec­ta­tionshad failed in a piv­otal Phase 3...

Cel­cu­ity said a com­bi­na­tion reg­i­men with its ex­per­i­men­tal drug geda­tolis­ib dou­bled pa­tients' like­li­hood of sur­vival with­out dis­ease pro­gres­sion or death in a late-stage breast can­cer...